Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma

Am J Gastroenterol. 2009 Jul;104(7):1852-4. doi: 10.1038/ajg.2009.140. Epub 2009 May 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Angiography
  • Benzenesulfonates / administration & dosage*
  • Carcinoma, Hepatocellular / diagnosis
  • Carcinoma, Hepatocellular / drug therapy*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Follow-Up Studies
  • Humans
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / drug therapy*
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neoplasm Invasiveness / pathology
  • Neoplastic Cells, Circulating / drug effects
  • Neoplastic Cells, Circulating / pathology*
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Portal Vein / pathology*
  • Pyridines / administration & dosage*
  • Risk Assessment
  • Sorafenib
  • Treatment Outcome

Substances

  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib